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Atypical lymphocytes are reactive lymphocytes that 
play an important role in the immune response. It was 
originally described by Turk as ‘Turk Cell’ in 1907 
in the peripheral blood of a patient with infectious 
mononucleosis. In 1923, Downey and McKinley, based 
on the cytoplasmic appearance and the distribution and 
quantity of chromatin, further classified them into;
• Type 1 Downey Cells (fig. 1): Nucleus is irregular 
or it may be round or oval (in this case it may be 
indented). The nuclear chromatin resembles that of 
a mature lymphocyte. It has a basophilic cytoplasm 
that may be foamy and vacuoles may be present.
Fig. 1. Type 1 Downey Cell
• Type 2 Downey Cells (fig. 2): Nucleus has coarse 
chromatin (less than in the type I cell). Cytoplasm 
has a scalloped appearance (appear to have flowed 
around adjacent RBCs) and is increased in quantity. 
It stains light blue around the nucleus but more 
intense blue at the periphery (basophilic). There 
may be radial basophilia. Vacuolation is less than 
in type 1 and azurophilic granules may be seen.
• Type 3 Downey cells (fig. 3): Nucleus resembles 
immature lymphocyte and nucleoli (one to four) 
may be visible. Cytoplasm is highly basophilic and 
abundant. This cell is larger than types 1 and 2.
    
Fig. 3. Type 3 Downey cell
Atypical lymphocytes are present in both viral and 
bacterial infections. These are usually 10 to 15 µm in 
diameter. In severe infections, they may develop into 
plasmacytoid lymphocytes and plasma cells. They are 
non-malignant and appear as a non-specific response 
to stress from a variety of stimuli. 
Causes of atypical lymphocytosis are listed in Table 1.
Atypical lymphocytes should be morphologically 
differentiated from the atypical lymphoid cells of 
lymphoma or malignancy on the basis of size, nuclear 
and cytoplasmic features. Atypical lymphocytes are 10 
to 15 µm in diameter with an abundant, irregular and 
basophilic cytoplasm. The nucleus is slightly larger with 
open chromatin. In comparison, atypical lymphoid 
cells are variable in size depending on the type of 
malignancy involved. The cytoplasm is agranular, 
scanty with varying degree of basophilia and the 
nucleus is irregular lobed, indented or cleaved.
The Atypical Lymphocytes
Dr Shabneez Malik and Roohi Noman
Haematology
Fig. 2. Type 2 Downey Cell
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Infections Infectious Mononucleosis (in which it is frequently ≥30%)
Toxoplasmosis
Rubella
Mumps
Tuberculosis
Hepatitis A & B
Drug and toxic reactions Lead poisoning
Hormonal Addison’s disease 
Thyrotoxicosis
Auto immune disorders Rheumatoid arthritis
Systemic Lupus Erythematosus (SLE)
Idiopathic thrombocytopenic purpura
Malignancy Hodgkin’s disease
Idiopathic Sarcoidosis
Guillain-Barre Syndrane
Myasthenia gravis
Graft rejection Renal
Others Immunisation, radiation
Table 1: causes of atypical lymphocytosis
High Performance Liquid Chromatography 
(HPLC):  An Effective Tool for the Diagnosis 
of Various Hemoglobinopathies
Mashhooda Rasool Hashmi
Haematology
Cation Exchange high performance liquid chrom-
atography (HPLC) is a process in which a mixture of 
molecules (such as normal or variant haemoglobins) 
with a net positive charge is separated into its 
components by their adsorption onto a negatively-
charged stationary phase in a chromatography 
column, followed by their elution by a mobile phase. 
The mobile phase is a liquid with an increasing 
concentration of cations flowing through the column. 
After elution, these molecules are provisionally 
identified by their retention time and then quantified 
spectrophotometrically.
The application of HPLC to the identification of 
variant haemoglobins depends on the fact that, 
for each normal or variant haemoglobin, there is a 
characteristic period of time, referred to as retention 
time before the haemoglobin appears in the elute. In 
this manner, a complete separation of almost all kinds 
of haemoglobins can be achieved, including various 
overlapping haemoglobins like S and D.
A complete blood count along with a thorough review 
of peripheral film is essential in the assessment of 
haemoglobinopathies to reach a correct diagnosis. 
Variant haemoglobin identification by HPLC is 
basically a screening test and any haemoglobinopathy 
identified through it should be confirmed by molecular 
studies. Being a screening test, it has an importance 
in premarital or antenatal screening as well as in the 
neonatal diagnosis of various haemoglobinopathies, 
particularly thalassemias.
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The automated HPLC instruments currently in use are 
of a high precision and are moderately rapid. They 
use especially designed microbore columns, high 
precision gradient-forming liquid pumps and optical 
detectors.
HPLC has the following advantages over haemoglobin 
electrophoresis:
• The technique is less labour sensitive
• A very small sample is adequate
• Quantification of normal and variant haemoglobins 
 is available for each sample
• As haemoglobin A2 is quantified, β- thalassemia trait 
 can be diagnosed in a single procedure
• a large range of variant haemoglobins can be 
 identified
• compound heterozygote can be detected
• fast moving haemoglobins can be detected by manual 
 inspection of chromatogram
Considerable skill and experience is needed in 
interpreting the results of HPLC as the data produced 
are quite complex. Typical elution patterns of normal 
and some of the variant haemoglobins are shown in 
the following figures (1-4).
References 
Barbara J. Bain. Haemoglobinopathy Diagnosis, 
second edition black well 2001.
Fig. 1. chromatogram of a normal patient showing predominantly 
haemoglobin A and A2.
Fig. 2. chromatogram of a subject with β-thalassemia trait 
showing high A2
Fig. 3. chromatogram of a patient with β- thalassaemia major showing 
HbF only
Fig. 4. fast moving haemoglobin 
June 2010, Vol. 35, Issue 2
5
Platelet Transfusions: What We Need to Know
Mohammed Salman
Haematology
Platelet transfusions remain an integral part of 
treatment of haematology/oncology and surgical 
patients. Besides, these may be required in liver 
disorders, trauma setting and transplant setup.
Indications of platelet transfusions
Platelet transfusions are indicated in presence of 
active bleeding secondary to low platelets or platelet 
function defects (therapeutic usage). They may be 
required when bleeding is expected in the presence of 
very low platelet count (prophylactic usage).
1) Therapeutic usage
 Platelets are transfused in a patient with active 
 bleeding secondary to low platelets < 20 X 109/l 
 or bleeding secondary to platelets function defect. 
 Platelets are required in these circumstances if 
 other measures (anti-fibrinolytic agents, DDVAP 
 etc) have failed to secure haemostatsis.
It should be noted that patients having fever, sepsis, 
coagulopathy or anatomic bleeding may have higher 
threshold for platelets transfusion.
2) Prophylactic usage
 Prophylactically, platelets are given to a patient 
 with platelet count <10 X 109/l even in the absence 
 of bleeding. The reason being such patients are at 
 risk of intracranial bleeding. Other indications for 
 prophylactic use include:
i.  Non-bleeding patients with temporary myelo-
 suppression due to chemotherapy or radiotherapy or 
 underlying disease (e.g. leukemia) in the presence 
 of fever or minor haemorrhagic signs.
ii. Impending surgery or invasive procedures involving 
 the CNS or other critical areas in which micovascular 
 bleeding is harmful.
iii.Other minor surgery or invasive procedures where 
 the external pressure can be utilised to maintain 
 haemostasis can be performed at a platelet count of 
 50 X 109/l.
iv. Qualitative platelet function defect should be 
 considered for patients with von Willebrand disease 
 or qualitative function defect undergoing invasive 
 procedures.
v. Open heart surgery patients with micro vascular 
 bleeding having coagulopathy or low platelet or 
 their dysfunction.
Efficacy of platelet transfusion
This can be assessed clinically and by observing 
the haemostatic response. The response can also be 
monitored in the laboratory by evaluating platelet 
count one hour and 23 hours after platelet transfusions 
which should demonstrate an increment in platelet 
concentration.
However, the efficacy of platelets transfusions can be 
influenced by conditions such as uremia, medications, 
coagulation disorders, alloimmunisation to platelet 
HLA antigens, infections or splenomegaly.
Some important considerations while transfusing 
platelets
i. ABO identical or compatible platelets are preferred. 
 However, in adults ABO incompatible platelets 
 may be used because the amount of plasma is very 
 rarely of clinical concern. 
ii. Platelets do not carry Rh or D antigen. Therefore 
 Rh grouping is never a matter of concern while 
 transfusing patients. However, Rh negative 
 females of reproductive age group should be given 
 Rh negative platelets because of the risk of possible 
 red cells contamination of platelets or be considered 
 for Rh immunoglobulins in such cases. 
iii. Patients at risk for transfusion associated graft-
 versus host disease (TA-GVHD) should receive 
 gamma irradiated platelets.
Types of Platelets available at AKUH
There are two types of platelet products that are 
available at AKUH:
Random donor platelets (RDP) 
This is derived from a unit of whole blood after 
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centrifugation (Fig. 1). Each random donor platelet 
contains 50x109/1 platelets in approximately 50 ml 
of plasma. The recommended dose of random donor 
platelet is 1 unit/10kg body weight. The expected 
increment in platelets count is 5-10 X 109/l per unit of 
platelet transfused.
        
Single donor platelets (SDP) 
In contrast to RDP, it is obtained from a single donor 
by the process of aphaeresis which takes 1-2 hours 
for completion (Fig. 2 and 3). A single donor platelet 
contains 200-300 ml of plasma and has 300 X 109 
platelets approximately. For adults one single donor 
platelets unit is the therapeutic dose and for children, 
a single donor platelet unit may be split or alliquoted. 
The expected platelet count increment from a single 
donor platelet unit in an adult is 25-50 X 109/l.
Difference between RDP and SDP
The use of single donor platelets obtained by apheresis 
has increased substantially in the past decade in part 
because of perceptions that single donor platelets are a 
better transfusion product. SDP are more expensive than 
random donor platelet concentrates, and comparative 
studies have shown that post-transfusion platelet 
increments and the incidence of alloimmunisation are 
similar, using the two preparations. 
With improved donor screening, it is unlikely that 
there would be any detectable difference between 
the two platelet products in terms of the incidence of 
infectious disease transmission. Though some studies 
have suggested a reduction in bacterial transmission 
by transfusion with the use of single-donor platelets. 
Thus, except in cases where histocompatible donors 
are needed for alloimmunised patients, there is no 
compelling reason to choose single donor over random 
donor platelets. 
How platelets are stored in a blood bank    
Both RDP and SDP can be stored up to five days at 
20-24°C with continuous agitation to prevent 
clumping. Storage is limited to five days due to the 
risk of bacterial contamination. 
Quality Assurance of Platelets
Safeguarding the safety and quality of platelets is of 
crucial importance.
Currently, AKUH blood bank assures quality according 
to FDA and AABB guidelines for various blood 
products: firstly blood is collected only from healthy 
donors. Secondly, we monitor pH and sterility of  the 
platelets bag. Also, storing platelets in an incubator 
within temperature limits assures safety from bacterial 
contamination.
References
1. Consensus Conference on Platelet Transfusion 
 (1998); Synopsis of background papers and 
 consensus statement. British Journal of 
 Haematology. 101:609-617.
                       
2. Guidelines for the Use of Platelet Transfusions 
 (2008). British Journal of Haematology.
3. American Association of  Blood Bank; sixteenth 
 edition.
Fig. 1: Random donor platelets 
Fig. 2: Single donor platelets
Fig. 3: A donor donating platelets by apheresis
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in atherosclerotic and thrombotic vascular disease in 
the general and in end-stage renal disease (ESRD) 
population as well.
Most studies so far have indicated normal plasma 
homocystiene level to be in the range of 5 to 15µmol/L. 
However, this does not imply that there is of risk associated 
with homocysteine levels between 10 to 15 µmol/L.
In 1990, the cutoff for homocysteine level was greater 
than 20 µmol/ L. This number continued to go lower, 
and today a level somewhere around 12 µmol/ L 
is considered cutoff. Homocysteine analyses in 
NHANES III survey results shed some light into what 
constitutes ‘normal’ homocysteine levels in the US 
population. A 1999 study by NHANES investigators 
(published in Ann Intern Med 1999; 131: 331) 
showed that homocysteine levels continue to increase 
as a person ages, and that men have a higher mean 
concentration than women. 
In AKUH clinical laboratory homocysteine levels are 
determined by Fluorescence polarization immunoassay 
(FPIA). Normal range is taken from 4.72 -14.05, both 
for males and females. 
Measuring Homocysteine Levels  
Dr Fareeduddin Mazhar
Chemical Pathology
Homocystiene is a sulphur-containing amino 
acid, formed during metabolism of methionine. 
It is metabolized by pathways, remethylation and 
transsulfuration of methionine (Fig 1). Approximately 
50 per cent  of homocysteine generated from 
methionine is metabolized to cystathionine by 
cystathionine beta synthase (CBS). This is a one-way 
reaction that permanently removes homocysteine from 
the methionine cycle and initiates the transsulfuration 
pathway for the synthesis of cysteine and glutathione. 
In remethylation, homocystiene acquires a methyl 
group either from N5 methyltetrahydrofolate (in all 
tissues) or from betaine (in liver and kidneys) to form 
methionine. The former methylation step requires 
folate and vitamin B12 as cofactors in transsulfuration 
pathways are effective when there is excess of 
methionine or cysteine synthesis is required. 
Elevated plasma homocysteine is associated with 
increased incidences of cardiovascular mortality, 
stroke,  dementia and Alzheimer’s disease,  bone 
fracture, and higher prevalence of chronic heart failure. 
It was also shown that elevated plasma homocysteine 
is a risk factor for preeclampsia and neural tube 
defects (NTD). Homocysteine has been implicated 
Fig. 1: Metabolism of Homocysteine 
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Parathyroid Hormone: A Marker of
Vitamin D Deficiency and Insufficiency
Dr Aysha Habib Khan
Chemical Pathology
Vitamin D (25OHD) and parathyroid hormone (PTH) 
are important in both bone health and disease. In the 
past decade, there has been an increasing appreciation 
of the complexity and importance of their regulation 
and actions. 
Widespread prevalence of Hypovitaminosis D has 
been identified worldwide. Surprisingly it is more 
common in people living in tropical zones than 
inhabitants of the countries where sunshine exposure is 
considered insufficient. Countries at low latitude have 
also shown a high prevalence of vitamin D deficiency, 
ranging from 50 to 97%. The suggested mechanism 
is customary clothing in countries like Middle East 
leading to a high prevalence of vitamin D deficiency. 
Similarly, a high prevalence of vitamin D deficiency is 
also reported from Pakistan.
Levels of 1,25-dihydroxyvitamin D (1,25(OH)2D), 
which is the biologically active form of vitamin D, 
are tightly regulated by parathyroid hormone (PTH), 
phosphate and calcium. Vitamin D deficiency causes 
a compensatory increase in PTH, in an effort to 
maintain calcium (secondary hyperparathyroidism). 
However, not all patients with hypovitaminosis D 
will necessarily show hyperparathyroidism. The term 
‘vitamin D insufficiency’ defines a level at which the 
decreased vitamin D causes an increase in PTH. It has 
been suggested that the lowest vitamin D level that 
does not produce a rise in PTH should be selected as 
optimal. Magnesium deficiency may cause a blunted 
response to PTH.
Assumptions about vitamin D status should not 
be made based on PTH and calcium values, and 
25(OH) vitamin D measurements should be 
requested when vitamin D deficiency is clinically 
suspected, irrespective of biochemical results. This 
depends on cost-benefit ratios that various physicians 
ascribe to testing for deficiency versus treating for 
suspected deficiency. Vitamin D deficiency can 
have several causes, and the pattern of laboratory 
values with respect to 25-hydroxyvitamin D and 
PTH and response to vitamin D supplementation 
may help lead to identification of an  underlying 
pathology. 
Surrogate Measures of Insulin Sensitivity 
Dr Sahar Iqbal
Chemical Pathology
Both insulin resistance and impaired pancreatic beta 
cell function contribute to the chronic hyperglycemia 
in type 2 diabetes. Whereas insulin resistance is 
present several years before the manifestation of 
diabetes, impaired beta cell function is usually not 
seen until glucose tolerance becomes impaired. The 
relative contribution of impaired beta cell function 
and insulin resistance in the development of glucose 
intolerance and diabetes can be assessed by different 
methods.
Methods available for assessment of insulin 
sensitivity
1) Hyper-insulinemic euglycemic clamp 
 This test is considered as gold standard for the 
 assessment of insulin sensitivity but is laborious 
 and expertise is required to carry out the test. 
2) Intravenous glucose tolerance test 
 This test is also compatible with hyper-insulinemic 
 euglycemic clamp but also requires expertise.
3) Homeostasis model assessment insulin 
 resistance index (HOMA – IR) 
 This test estimates insulin  sensitivity from 
 measurement of fasting insulin and glucose.
4) Insulin sensitivity index (Si)  
 This test estimates the insulin sensitivity from 
 insulin and glucose response during an oral glucose 
 tolerance test (OGTT).
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The relative assessment of  the risk of type 2 
diabetes mellitus can be estimated by an insulin 
sensitivity index as resistance to insulin is developed 
before the manifestation of metabolic syndrome 
(hyperglycemia, hypertension, hyperlipidemia and 
hyperinsulinism which can lead to coronary artery 
disease and stroke).
In the AKUH clinical laboratory the insulin sensitivity 
test is conducted through OGTT in which two fasting 
blood samples of insulin and glucose are taken 
(at -15 and 0 minutes) followed by administering 
75 g of glucose orally; then six more blood samples are 
taken for insulin and glucose at 30 minutes intervals 
for 180 minutes post-load. Whole body insulin 
sensitivity index (WBISI) is calculated through a 
calculation with fasting and mean of post-load values 
of serum insulin and glucose. Normal WBISI in normal 
glucose tolerance is 2.02,  2.16; however the lower the 
sensitivity the higher the resistance is expected. 
Serum Insulin levels are measured at section of 
Clinical Chemistry through MEIA technique at AXYM 
(Abbott diagnostics) having functional sensitivity of 
1.0 µU/ml. 
Reference
Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour 
S, Burgert TS, et al. Validation of insulin sensitivity 
indices from oral glucose tolerance test parameters 
in obese children and adolescents. J Clin Endocrinol 
Metab. 2004 Mar; 89 (3): 1096-101.
Foetal Autopsy
Dr Sidra Arshad
Resident, Histopathology
An autopsy-also known as a post-mortem examination 
or autopsia cadaverum is a medical procedure that 
consists of a thorough examination of a corpse to 
determine the cause and manner of death and to 
evaluate any disease or injury that may be present. It 
is usually performed by a pathologist. 
The question is what is the significance of a foetal 
autopsy? Clinicians should advise parents of the 
usefulness of a foetal autopsy in ascertaining the cause 
of death and this would in turn help in counseling their 
future pregnancies.
Since it is a useful and necessary tool for helping 
determine the cause of foetal death, it should be 
approached in a systematic and meticulous manner 
by paying close attention to every fine detail of 
external and internal gross examination followed by 
microscopic examination. 
Components of the foetal autopsy 
In order to be consistent and thorough in approach for 
every autopsy, the Autopsy Committee of the College 
of American Pathologists, with representatives of 
other interested organisations, prepared a guideline to 
assist pathologists in reporting foetal autopsies. 
The complete medical record is reviewed to obtain the 
clinical history, with attention to medical obstetrical 
(past and present), and genetic conditions potentially 
associated with still birth. 
The following examinations are commonly 
performed: 
• Appropriate length of gestation
• General conditions: well preserved or macerated?
• Gross external examination with detailed 
 description and photographs of abnormalities, 
 dysmorphic features, and pertinent negative 
 findings 
• Gender
• Foetus  weight and external measurement
-  Crown-to-rump length (crown to ischial   
 tuberosities, ‘sitting height’) 
- Crown-to-heel length (crown to heel of extended 
 leg) 
- Foot length
- Hand length 
- Head circumference (i.e. occipitofrontal 
 circumference - above ears)
- Chest circumference (around nipples)
- Abdominal circumference (at umbilical 
 insertion) 
• Gross description of the placenta and cord: weigh 
 placental membranes, cord length and number of 
10
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 vessels. A short cord can be a sign of neuromuscular 
 compromise, a long cord can be a sign of heart 
 failure, while a single umbilical artery can be 
 associated with genitourinary anomalies (eg. renal 
 agenesis, horseshoe kidney)
• Gross and microscopic examination of major 
 organs, anomalies, including the weight of each 
 organ. Paired organs are weighed together
• X-rays may reveal unrecognised skeletal 
 malformations, or can be obtained to further 
 evaluate suspected skeletal abnormalities. Plain 
 whole body anteroposterior and lateral radiographs 
 are taken with the infant’s head ‘straight’
• Foetal radiographs should be examined carefully 
 by the autopsy pathologist for specific findings, 
 such as:
- Appropriate ossification of bones for gestational 
 age 
- Documentation and timing of fractures (which 
 should be sampled histologically)
- Presence of ectopic mineralisation/ossification 
 of non-bony tissues
Sections from the foetal and placental tissues should 
be processed for histological examination in all cases, 
even when severely autolysed or structurally normal. 
Important pathologic findings that have clinical 
relevance beyond that of identifying a cause of death 
can still be diagnosed in severely autolysed tissues.
Cytogenetic studies may be performed on the stillborn’s 
blood, tissue, or body fluids (for example bile, urine, 
vitreous humour), as long as the cells are viable. Blood 
can be collected from the umbilical cord and skin 
samples are usually taken from the thigh after cleaning 
with normal saline. Fresh tissue samples should be 
placed in sterile medium (for example Hanks balanced 
salt solution) from the cytogenetics laboratory, or 
sterile saline solution, and kept at room temperature 
(do not use fixatives such as formaldehyde). In cases 
of moderate or marked autolysis, the umbilical cord or 
chorionic plate vessel can be sampled for karyotype 
analysis. Microbiologic studies can be performed on 
foetal blood taken from the heart or umbilical cord; 
however, foetal blood is more easily obtained from the 
foetal lung at autopsy.
Foetal autopsies should be performed with the 
care and respect that all autopsies are given. Also, 
it is not uncommon for a family to decide to view 
the body after the postmortem examination has 
been done; therefore careful dissection to avoid 
any disfigurement is important. Even the smallest, 
youngest (in gestational age), and most autolysed 
cases can receive a thorough post-mortem examination 
and be returned in a condition suitable for viewing 
management.  Finally, autopsy reports should be 
completed promptly so that a family meeting with 
the clinicians can be timely.
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Laboratory Diagnosis of Vaginitis due to 
Trichomonas Vaginalis
Dr Naima Fasih
Resident, Microbiology
Introduction  
Trichomoniasis is a sexually transmitted protozoal 
infection caused by Tricomonas Vaginalis. Women 
and men may be asymptomatic carriers, or they may 
experience most commonly, foul smelling purulent 
discharge and itching. It sometimes occurs as co-
infection with other STDs and therefore is a public 
health concern. T. vaginalis inhabits the vaginal 
and urethral tissues, causing direct damage to the 
epithelium, leading to microulcerations. Symptoms 
typically occur after an incubation period of 4-28 
days.
Laboratory Diagnosis  
Following are the commonly used tests for the 
diagnosis of T. vaginalis:
• Wet mount 
• Culture
• Giemsa stain
Other tests that can also be used in the laboratory are:
• DNA probe
• Latex agglutination
• Enzyme-linked immunoassay
• Direct fluorescent antibody staining
• RNA probe semi automated system
Direct Wet Mount
The identification of T. vaginalis is usually based 
on the examination of a wet preparation of vaginal 
and urethral discharges, prostatic secretions or urine 
sediments. Specimens are diluted with a drop of 
saline and are examined within one hour under low 
power. The presence of actively motile organisms 
with jerky motility is diagnostic. The movement of the 
undulating membrane may be seen as the motility of 
the trophozoite diminishes. Pus cells are often present. 
The sensitivity of the wet preparation is between 50 
and 70 per cent and is largely affected by the time 
between collection and examination of the specimen. 
This test is available at the clinical laboratory of Aga 
Khan University Hospital.
Culture 
Culture has increased sensitivity (>80 per cent) than 
the wet mount and is considered as a gold standard. 
Specimens must be collected properly and inoculated 
as soon as possible on appropriate medium, i.e. 
Modified Diamonds, Trichosel or Hollanders medium. 
Immediate processing is mandatory for maximum 
recovery of organisms. This approach is not routinely 
used in clinical laboratories. Culture systems which 
allow direct inoculation, transport, culture and 
microscopic examination are commercially available. 
Giemsa Stain 
This stain is also used routinely but the sensitivity is 
low as organisms are often difficult to recognize.
References
1. Henry D Isenberg. Clinical Microbiology 
 Procedure Handbook, 3rd ed. Vol. 1 ASM 
 Press.
Fig. 1: Trophozoites of T. vaginalis (Image taken from 
www.dpd.cdc.gov/dpdx/HTML/ImageLibrary/Trichomoniasis_il.htm)
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AKUH Clinical Laboratory Continuing 
Medical Education (CME) Seminars
Reported by
Seema Vaqar
CME Seminar in Nawabshah 
The CME Seminar was held at Latif Hall, Peoples 
Medical College & Hospital (PMCH), Nawabshah 
with the collaboration of Department of Pathology 
and Microbiology on March 2, 2010. It covered a 
broad range of topics on infectious hepatitis B, C, and 
D diseases and swine flu, aplastic anaemia and role of 
histopathologist as diagnostician & prognostician in 
the management of cancer. 
It was well attended and about 600 health care 
professionals, students, staff and faculty members 
from local area hospitals and academic institutions 
participated. Professor Dr Azam Hussain Yousifani, 
Principal of the College, presided over the session.
In his opening statement, Professor Dr Rasool Bux 
Shaikh, pathologist from PMCH shared the mission of 
AKUH clinical laboratory by conducting such seminars. 
He highlighted the role of AKUH pathologists in 
education and provision of high quality nationwide 
diagnostic services and invited the Chief Guest, 
Professor Azam Hussain Yousifani for his welcome 
remarks.
Professor Azam Hussain Yousifani applauded the 
effort and initiatives of the speakers from AKU in 
terms of disseminating knowledge and sharing their 
experiences with health care professionals in other 
parts of the country. He further highlighted the role of 
these seminars in educating the students and staff of 
academic institutions. 
 
Dr Usman Sheikh, Assistant Professor and Consultant 
Haematologist, AKU impressed the audience with a 
lucid and engaging presentation on Aplastic Anaemia. 
He referred to data obtained by the AKUH clinical 
laboratory of Aplastic Anemia within the country and 
emphasized the early diagnosis and management of 
the disorder. 
Dr Seema Irfan delivering a talk on viral hepatitis
Dr Usman Shaikh addressing the audience at CME Seminar
Dr Abrar Barakzai addressing the audience at  CME Seminar
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Dr Seema Irfan, Assistant Professor AKU delivered a 
lecture on hepatitis B, C and D Virus and discussed 
the interpretation of serological and PCR results 
and epidemiology of HCV and HBV in Pakistan, 
especially in Sindh. She highlighted the importance 
of viral genotyping as well as testing for viral load in 
diagnosis and treatment of hepatitis B and C. 
Dr Abrar Barakzai, Assistant Professor, AKU provided 
an overview of various tumors and cancer. He 
emphasized the significant role of histopathologists 
in the diagnosis and prognosis of cancer management 
and showed national cancer data reflecting a high 
prevalence of oral cavity and lung cancers in Sindh 
as compared to other regions of Pakistan. He also 
highlighted the role of immuno-histochemistry in the 
proper diagnosis of cancer.  
Dr Anwar Ali Akhund, Professor of Pathology, 
PMCH Nawabshah presented a lecture on Swine Flu 
infection and discussed prevention of Swine Flu and 
its management. 
The seminar was successful as indicated by the interest 
of the audience in the question and answer session. 
Dr Abdul Qayoom Memon, Professor of Medicine, 
ended the seminar by delivering a vote of thanks. 
Before closing, the chief guest, Prof. Azam Hussain 
Yousifani presented shields and Ajrak to the guest 
speakers. 
Participants at the Seminar 
Question-answer session at the Seminar
Speakers of CME Seminar along with Principal and Faculty of Peoples Medical College and Hospital, Nawabshah
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CME Seminar in Rahim Yar Khan
This year the clinical laboratory has started ‘Focus 
Continuing Medical Education’ seminars. The objective 
is to involve with local pathologists and physiciansin 
order to develop a strong and long-term relationship.
Our first focused CME for 2010 was held in Rahim 
Yar Khan on March 25th. It was well attended - 
about 50 doctors from all major specialties including 
medicine, surgery, gastroenterology and the pathology 
departments of Sheikh Zaid Hospital were present on 
the occasion.
In his opening statement Dr Asghar Javaid, Staff 
Pathologist of Multan Stat Lab shared the mission 
of AKUH Clinical Laboratory of conducting such 
seminars and Focus groups. He also highlighted 
the role of AKUH pathologists in educating as well 
as providing high quality diagnostic services for 
physicians and hospitals nationwide.
Dr Romena Qazi, Section Head of Molecular 
Pathology spoke on Detection, Genotyping of 
hepatitis C. She also shared the data for the prevalence 
of hepatitis C in the world. She emphasised the 
importance of proper diagnosis of hepatitis C.
Dr Irfan Ahmed, gastroenterologist and Professor 
of Medicine, Sheikh Zaid Hospital spoke on the 
management of hepatitis C. He also highlighted 
the symptoms and the root cause of hepatitis C and 
also gave the standard protocol for the treatment of 
hepatitis C.
Finally there was a lively question and answer session, 
the event concluded on a successful note.
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